Aprotinin in the management of coagulopathy associated with amniotic fluid embolus

Jeffrey S. Stroup, G. Davin Haraway, J. Martin Beal

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Amniotic fluid embolus, also known as anaphylactoid syndrome of pregnancy, is a rare complication of pregnancy. When it occurs, the maternal mortality rate may be as high as 86%, and in survivors, the morbidity rate may be just as high. Hallmark clinical features include maternal cardiovascular collapse with cyanosis, cardiopulmonary arrest, hypotension, hemorrhage associated with disseminated intravascular coagulation, and fetal distress. Management centers on strategies to improve oxygenation, support circulation, and correct the coagulopathy We report the case of a patient who developed amniotic fluid embolus and was effectively managed with aprotinin to control the coagulopathy associated with this devastating complication of pregnancy.

Original languageEnglish
Pages (from-to)689-693
Number of pages5
JournalPharmacotherapy
Volume26
Issue number5 I
DOIs
StatePublished - May 2006

Keywords

  • Amniotic fluid embolus
  • Anaphylactoid syndrome of pregnancy
  • Aprotinin
  • Coagulopathy

Fingerprint Dive into the research topics of 'Aprotinin in the management of coagulopathy associated with amniotic fluid embolus'. Together they form a unique fingerprint.

  • Cite this